High Molecular Weight Poly(ethylenimine)-Based Water-Soluble Lipopolymer for Transfection of Cancer Cells by Abd Elhameed, Heba Alaa Eldeen Hosiny et al.
www.mbs-journal.de
© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim2000040 (1 of 10)
Full PaPer
High Molecular Weight Poly(ethylenimine)-Based Water-
Soluble Lipopolymer for Transfection of Cancer Cells
Heba Alaa Hosiny Abd Elhameed, Ditta Ungor, Nóra Igaz, Mohana Krishna Gopisetty, 
Mónika Kiricsi, Edit Csapó, and Béla Gyurcsik*
H. A. H. Abd Elhameed, Dr. B. Gyurcsik
Department of Inorganic and Analytical Chemistry
University of Szeged
Dóm tér 7, Szeged H-6720, Hungary
E-mail: gyurcsik@chem.u-szeged.hu
DOI: 10.1002/mabi.202000040
numerous limitations such as potential 
carcinogenesis, immunogenicity, limited 
DNA packaging size, and difficulty in pro-
duction.[5] Non-viral vectors are preferred 
for gene delivery purpose because these 
systems have shown less side-effects.[6–9]
The widely used physical delivery 
methods applied with non-viral vehicles 
depend on creating a simple pierce in the 
cell membrane by electroporation, micro-
injection, induced transduction, mechan-
ical cell deformation, and hydrodynamic 
injection. Thus, they are rather convenient 
for in vitro applications. Chemical vehicles 
such as lipid or polymeric nanoparticles, 
cell-penetrating peptides, DNA nanostruc-
tures, and gold nanoparticles hold enor-
mous potential for in vivo applications. Cat-
ionic polymers such as poly(ethylenimine) 
(PEI), polylysine, amine-functionalized 
poly-caprolactone, and chitosan are widely 
used as gene carriers. These can be pre-
pared easily and have a high DNA pack-
aging ability at physiological pH.[10,11] 
Among them, PEI is one of the leading 
transfection reagents because of the high 
concentration of positively charged amino groups, interacting 
strongly with the negatively charged DNA, forming condensed 
DNA/PEI complexes, and ultimately protecting the genetic 
material from the enzymatic degradation.[12–14] The first appli-
cation of PEI as transfection reagent was published in 1995.[15] 
Branched and linear PEIs have been utilized ever since to 
deliver nucleic acids both in vitro and in vivo.[16,17] PEI-based 
nanocarriers promote efficient transfection.[18–20] Modification 
Over the past decade, search for novel materials for nucleic acid delivery 
has prompted a special interest in polymeric nanoparticles (NPs). In this 
study, the biological applicability of a water-soluble cationic lipopolymer 
(WSLP) obtained by the modification of high molecular weight branched 
poly(ethylenimine) (PEI) with cholesteryl chloroformate is characterized 
and assessed for better cellular membrane permeability. To test the delivery 
efficiency of the produced lipopolymer, plasmid DNA (pDNA) encoding the 
enhanced green fluorescent protein and WSLP are mixed at different charge 
ratios. WSLP and WSLP/pDNA complexes are characterized by dynamic and 
static light scattering, particle charge detection, scanning electron micros-
copy, and transmission electron microscopy. The pDNA loading of WSLP is 
also verified by agarose gel electrophoresis. Cytotoxicity of PEI, WSLP, and 
of WSLP/pDNA is evaluated on human A549 and HeLa cells. A remarkable 
dependence of the toxicity on the dose, cholesterylation, and charge ratio 
is detected. Transfection is monitored by flow cytometry and by fluores-
cence microscopy. Importantly, cholesterylation decreases the toxicity of the 
polymer, while promoting high transfection efficiency in both cell lines. This 
work indicates a possible optimization mode of the high molecular weight 
PEI-based WSLP rendering it a promising candidate for gene delivery.
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1. Introduction
Gene therapy offers a potential cure for hereditary diseases. 
For effective clinical application, the development of compe-
tent gene delivery systems is essential.[1–4] To this date mainly 
two types of delivery approaches are available using either viral 
or non-viral vehicles. Viral vectors (adeno-associated virus and 
lentivirus) are efficient gene delivery systems but they have 
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of PEI using different polymers and ligands has recently been 
widely studied to overcome the limitations of its application, 
such as the increasing cytotoxicity with increasing molecular 
weight and aggregation in the case of high ionic strength.[21–35]
Along this line, herein we used high molecular weight 
(HMW) branched PEI-based cationic water-soluble lipopolymer 
(WSLP) for non-viral gene delivery. Our system contained PEI 
primarily to enhance plasmid DNA (pDNA) condensation and 
its endosomal release due to its tertiary amines, and the cho-
lesteryl groups served as the lipid component to increase the 
transport of pDNA through the cell membranes. The pDNA 
loading was monitored by physico–chemical methods, while 
the cytotoxicity and transfection efficiency were evaluated by 
a colorimetric assay based on 3-[4,5-dimethylthiazol-2-yl]-2,5- 
diphenyltetrazolium bromide (MTT assay) and by flow cytom-
etry, as well as fluorescence microscopy based on the enhanced 
green fluorescent protein (EGFP) fluorescence, respectively.
2. Results and Discussion
2.1. Synthesis and Characterization of Water-Soluble Lipopolymer
WSLP was prepared from PEI and cholesteryl chloroformate 
as described in the Experimental Section. The reaction is sche-
matically depicted in Figure 1. By the multiple purification steps 
performed, the impurities and unreacted starting materials have 
been completely removed from the product. Due to the balanced 
ratio between the hydrophilic PEI and lipophilic cholesterol, the 
prepared WSLP is well soluble in water. The average molecular 
weight of PEI was not provided and therefore, we had to deter-
mine it using dynamic light scattering (DLS) measurements as 
Mw ≈  139 ±  1  kDa (Figure S1, Supporting Information). How-
ever, the same method was not suitable for the determination of 
the increased molecular mass of WSLP, because of the artefacts 
arising from the light scattering of some aggregates.
2.1.1. Determination of Critical Micelle Concentration
WSLP is able to behave like a surfactant and forms micelles in 
aqueous solutions thanks to its amphiphilic chemical structure. 
For the determination of critical micelle concentration (CMC), 
representing the concentration, above which the micelle for-
mation occurs, fluorescent Eosin red indicator was used. The 
fluorescence of the dyes is rather sensitive to the chemical envi-
ronment. The intensity of the fluorescence increases and the 
wavelength of the maximum intensity shifts in the presence of a 
number of surfactants.[36] At the same time, some multiple posi-
tively charged surfactants may quench the fluorescence.[37] It has 
also been reported that PEI is quenching the Eosin fluorescence 
due to the strong interaction of the negatively charged dye mol-
ecule with multiple positively charged surfactant.[38] Similarly, 
the increase of the WSLP concentration caused a decrease of 
the Eosin fluorescence intensity. As it can be seen in Figure 2, 
WSLP behaves as a quencher of the dye. Based on the measured 
data, it can be established that the polymer applied at higher con-
centration than CMC caused complete fluorescence quenching 
in contrast to the conventional monocationic surfactants, 
where the fluorescence of the dye starts to increase above of 
CMC.[39] The rapid decrease in the fluorescence intensity indi-
cates the development of micelles, while the intensity does not 
change further upon completion of this process. The CMC of 
0.35 ± 0.03 mg mL−1 was obtained by this method for the WSLP.
2.1.2. Particle Charge Detection
The WSLPs obtained by cholesterylation of low molecular 
weight PEI are usually characterized by nuclear magnetic reso-
nance (NMR) and matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry (MALDI TOF MS) in terms 
of the molecular weight and cholesterylation extent.[35,40–47] 
These methods perform well with small and medium size 
molecules, but become of limited use for compounds with the 
molecular weight with several hundreds of thousands Da. The 
broadening effect of the NMR bands due to the slow molecular 
tumbling can already be experienced with the WSLP having 
Mw >  10  kDa,[35,46,47] while according to our knowledge no MS Figure 1. Schematic representation of the WSLP/pDNA complex formation.
Figure 2. Representative determination of the CMC of WSLP by dye 
solubilization method using fluorescence spectroscopy (λex =  490  nm, 
λem =  540 nm), with the photos of samples in daylight and under UV-
lamp in the inset of the figure.
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data are published for high molecular weight PEI or WSLP. 
Therefore, we were looking for a readily available simple method 
for checking the cholesterylation extent. Since cholesterylation or 
the modification in general, may affect the specific charge of the 
polymer both through the reaction with the amine groups and 
through increasing the molecular weight, such measurements 
could provide useful information, independently of the size 
of the polymer. The specific charge of the polymers was deter-
mined by the titration of sodium dodecyl sulfate (SDS) by PEI 
and WSLP, and checking the charge neutralization points. As 
it can be seen in Figure 3, the negative streaming potential con-
tinuously increased by the increase of the amount of the poly-
mers. Based on the measured data, the charge compensation 
occurred upon adding of 6.5 mg PEI or 14.8 mg WSLP into the 
particle charge detector (PCD) cell. Knowing the applied amount 
of SDS, the specific charges of PEI and WSLP were calculated, 
to be q(PEI) =  15.38  mmol  g−1 and q(WSLP) =  6.76 mmol  g−1, 
respectively. Using these data and the molecular weight of the 
initial PEI (Figure S1, Supporting Information), the protonated 
fraction of PEI can be estimated. The theoretically maximal spe-
cific charge of the applied PEI polymer is 23.22 mmol g−1, sug-
gesting that ≈66% of the nitrogens are protonated in PEI under 
the measurement conditions. This is in very good agreement 
with the published values in the literature for branched PEI 
molecules determined from acid–base titrations.[48,49]
It can also be concluded that the specific charge has decreased 
in the cholesterylation step. The ratio of q(WSLP)/q(PEI) is 
≈0.44, meaning that the WSLP has 56% less specific charge 
than PEI. Since the specific charge, q depends on the molecular 
weight, Mw and the number of charges in a single molecule, 
n+ the decrease of the specific charge may occur both by the 
increase of Mw and decrease of the number of the protonated 
nitrogens according to Equation (1).
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The cholesterylation occurs at more reactive primary amine 
groups which have to be deprotonated under the reaction con-
ditions, but they might be protonated in a buffer solution at 
pH ≈ 7. An initial PEI molecule with Mw of 139 kDa contains 
3227 nitrogens, out of which ≈2138 are protonated based on 
the measured specific charge. The increase of the Mw may play 
major role in the decrease of the specific charge of WSLP com-
pared to PEI, if the number of protons at the nitrogens does 
not change as the consequence of the modification. In this case 
the increased Mw can be calculated from Equation (1), based on 
the specific charge value of the WSLP. This calculation yields 
≈316.5 kDa as the new Mw. This molecular weight is the sum 
of the original 139 kDa of the PEI and the mass increase due 
to the cholesterylation, that is: 316  492  =  139  000 + x(449.11 
− 35.45). Here, x is the number of the conjugated cholesteryl 
groups per a PEI polymer, which can be easily calculated to be 
x ≈ 429. This reveals that approximately 13% of the nitrogens 
have been cholesterylated. On the other hand, we also may carry 
out the calculation assuming that the charge on the new WSLP 
molecule is decreased by the number of the cholesteryl groups 
attached to the nitrogens of PEI. In this case Equation (1) will 
be used for the calculation of x in its following form:
6.76
1
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2138 1000
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From this, x  ≈ 316 is obtained. Thus, ≈10% is suggested 
for the possible fraction of the cholesterylated nitrogens. The 
molecular weight of the synthesized copolymer is ≈269.7  kDa 
by this assumption. The real number of the attached cholesteryl 
groups might be between the above two values assuming that 
no further deprotonation of the WSLP is caused by the modi-
fication. This calculation provides closer estimates for the pos-
sible domains of important parameters such as the molecular 
weight and the charge content of the newly prepared polymer.
2.2. Condensation Efficiency of the Water-Soluble Lipopolymer
WSLP/pDNA complexes are usually prepared by adjusting the 
mass or N/P ratios. It has to be mentioned that the two types 
of preparations cannot be directly compared with each other. 
The N/P ratio is the ratio of the number of nitrogen atoms of 
WSLP and the number of the phosphorous atoms of plasmid 
DNA. The number of nitrogen atoms is obtained by dividing 
the molecular weight of the polymer with the molecular weight 
of the monomer (there is one N atom in a monomer) and P 
atoms are calculated as 2000× kb of the plasmid DNA. For this, 
the knowledge of the molecular weight, that is, the extent of 
the modification of PEI, as well as the protonation state of the 
polymer is essential. It is usually very difficult to determine 
these parameters precisely.
We optimized the loading efficiency of WSLP using pEGFP-
N3 and pX458 plasmids within both the mass and the N/P 
ratios ranging from 1.25 to 20.0 as it is described in more detail 
in Chapter S1, Supporting Information. DNA loading ability of 
WSLP was monitored by agarose gel electrophoresis. The results 
on N/P ratio series are shown in Figure 4. On increase of the 
N/P ratio, free DNA could not be detected on agarose gel when 
the value of N/P ratio reached 5/1, confirming the effectiveness 
of condensation by the polymer. This is due to the fact that posi-
tively charged head groups of WSLP interact strongly with the 
Figure 3. Titration of SDS with PEI or WSLP solutions for the detection of 
the charge neutralization point in a charge particle detection experiment, 
as described in the Experimental Section.
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negatively charged phosphate ions in the backbone of plasmid 
DNA independently of its nucleotide sequence. Nevertheless, 
the specific charges put the case more clearly, since the specific 
charge of the DNA which should be 3.24 mmol g−1, can directly 
be compared with the specific charge of the polymer. At 5/1 N/P 
ratio the reaction mixture was constructed by mixing 1.00 µg of 
pDNA with 0.76 µg of WSLP. Based on the specific charges this 
corresponds to a positive/negative charge ratio of 5.14/3.24, that 
is, the total charge of the WSLP/pDNA complex is positive, while 
at N/P = 2.5/1 is still negative. This is in good agreement with 
the fact that the band of the DNA can be detected at N/P = 2.5/1 
ratio on the agarose gel, although its mobility is less than that 
of the free DNA. At the same time the DNA band at N/P = 5/1 
ratio does not appear. The mass ratio of 5/1 would correspond to 
a positive/negative charge ratio of 33.8/3.24, which means that 
this particle is already highly positively charged. Thus, by meas-
uring the specific charge of the polymers the preparations using 
various types of ratios become comparable with each other.
2.3. Characterization of WSLP/DNA Complexes
Preparations of WSLP/pEGFP-N3 and WSLP/pX458 complexes 
with various composition ratios were characterized by DLS to 
determine the particle size and ζ-potential. The loading of plas-
mids into the polymer with defined colloidal and surface proper-
ties plays a major role in controlling stability, biodistribution, and 
intracellular fate of formulated plasmids. In contrast to the large 
size of naked DNA,[50] complex formation between WSLP and 
plasmid DNA resulted small-sized particles. For WSLP/pEGFP-
N3 complexes, the mean particle size was in the range of 53.1–
268.6 nm depending on the N/P ratio. ζ-potential of WSLP/DNA 
complexes increased with the increase of the charge ratio. At the 
N/P ratio of 2.5/1, it was −22.4 mV, but increased to +15.3 mV 
when formulated at N/P ratio of 20/1 as shown in Table 1. The 
size and ζ potential values for WSLP/pX458 complexes differ 
from the WSLP/pEGFP-N3 complexes as shown in Table 2.
The WSLP/pEGFP-N3 complexes were characterized by scan-
ning electron microscopy (SEM) and transmission electron 
microscopy (TEM). The recorded images are shown in Figure 5. 
Both SEM and TEM detected the particle sizes being in good 
agreement with the values determined by DLS. The significant 
increase in size of the pDNA/WSLP nanoparticles (>100  nm; 
Figure  5D) in comparison with the WSLP itself (<50  nm; 
Figure 5C) is clearly demonstrated by TEM, supporting the suc-
cessful condensation of the negatively charged pDNA by the 
cationic lipopolymer. Also, the pure WSLP in most cases showed 
fibrous structure on solid surfaces (e.g., copper grid) as can be 
also seen on the Figure 5C, while the morphology became nearly 
spherical-like upon complexation with DNA. The image shown 
in Figure 5D suggests a core-shell-like architecture of the pDNA/
WSLP complex, which is assumed based on the different electron 
diffractions of the two components, due to their significantly dis-
tinct molecular weight. However, we could not unequivocally con-
firm such structure upon analyzing more particles (Figure 5E,F).
2.4. Cytotoxicity Assay
Since it is the major concern with many transfection protocols, 
we monitored the cytotoxicity of WSLP and WSLP/pEGFP-N3 
complexes on A549 and HeLa cell lines after 24 and 48 h incu-
bation at 37 °C using MTT cytotoxicity assays. According to the 
results shown in Figure 6, the polymer is only slightly toxic to 
the cells at 304 ng per well WSLP concentration. However, cell 
viability decreased significantly upon increase of the WSLP con-
centration, which indicates a remarkable dose-dependence of 
cytotoxicity. We have also checked the cytotoxicity of the WSLP/
pEGFP-N3 preparations as a function of the ratio of the two 
components. The average cell viabilities upon treatment with 
Figure 4. Agarose gel electrophoresis picture of naked pEGFP-N3 plasmid 
and WSLP/ pEGFP-N3 complexes formed by WSLP with the plasmid at 
N/P ratios 1.25, 2.5, 5, 10, and 20 in lanes 3–7, respectively.
Table 1. The average size and ζ-potential values of WSLP/pEGFP-N3 
plasmid complexes at different N/P ratios.
N/P ratio d [nm] ζ-potential [mV]
1.25/1 53.1 ± 9.5 −22.4 ± 0.4
2.5/1 93.2 ± 9.2 −25.3 ± 0.2
5/1 138.8 ± 24.6 −20.3 ± 1.1
10/1 142.5 ± 14.8 +1.9 ± 0.2
15/1 163.8 ± 39.2 +12.3 ± 0.5
20/1 268.6 ± 19.2 +15.3 ± 1.3
WSLP 36.7 ± 3.5 +61.6 ± 0.4
Table 2. The average size and ζ-potential values of WSLP/pX458 
plasmid complexes at different N/P ratios.
N/P ratio d [nm] ζ-potential [mV]
2.5/1 61.0 ± 4.7 −19.7 ± 4.9
5/1 63.1 ± 7.6 −3.2 ± 3.3
10/1 133.2 ± 5.2 +23.1 ± 4.5
20/1 131.9 ± 3.5 +28.9 ± 1.7
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WSLP/pEGFP-N3 of increasing N/P ratios from 5 to 20, decreased 
from ≈84% to ≈36% for A549 cells, and from ≈80% to ≈8%, for 
HeLa cells after 24 h. It is important to note that upon associa-
tion of the WSLP with the pDNA, the toxic effect did not increase 
compared to the WSLP itself. Cytotoxicity was reasonably low 
even at 10/1 N/P ratio for A549 cells, nevertheless it depended 
remarkably on the type of the applied cell. The microscopic 
images of the cells treated with WSLP/pEGFP-N3 complexes 
show that the majority of the cells are destroyed by the excess of 
WSLP (Figure S3, Supporting Information).
In Figure S2, Supporting Information, we compared the cyto-
toxicity of the preparations based on the mass and N/P ratios. 
The average cell viability decreased quickly upon treatments with 
WSLP/pEGFP-N3 complexes of increasing mass ratios from 5 
to 20, while adjusting the N/P ratios between 5 and 20 affected 
only slightly the viability of human A549 cells. We concluded 
that during the preparation of the WSLP/pDNA complexes the 
mass and N/P ratios may cause significantly different effects 
and the comparative evaluation of the results can only be accom-
plished considering the specific charges as described above. 
From these results, we can conclude that the minimization of 
the excess positive charges shall be targeted to decrease the toxic 
effect of the WSLP upon DNA delivery to the cells.
We have also checked the toxic effect of the WSLP prepa-
rations in comparison with the starting HMW PEI, as well 
as with the commercial standard transfection reagent Lipo-
fectamine 3000 (Thermo Fisher Scientific). The latter has sim-
ilar toxicity and transfection characteristics as the PEI25K often 
applied as a standard.[51–53] The results are included in Figure 
S4, Supporting Information, showing that original HMW PEI 
is extremely toxic to the cells, in agreement with the literature 
data, demonstrating the increasing toxicity by increasing Mw.[15] 
On the other hand, upon cholesterylation of this HMW PEI, 
the resulted WSLP performs similarly to Lipofectamine.
Figure 5. A,B) SEM images of the WSLP/pEGFP-N3 complex using 5/1 mass ratio preparations under different magnifications. C) TEM image of the 
WSLP itself. D–F) TEM images of selected WSLP/pEGFP-N3 nanoparticles from the 10/1 N/P ratio preparation.
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2.5. In Vitro Transfection
The transfection efficiency of WSLP/pEGFP-N3 complexes 
at various N/P ratios was determined in A549 and HeLa cells 
as shown in Figure 7 and Figure S5, Supporting Information. 
According to the results of flow cytometry, the most efficient 
transfection was achieved at 20/1 N/P ratio in both cell lines. 
This can be surprising, since the MTT assays revealed that the 
20/1 N/P ratio preparation caused more significant cytotox-
icity than the preparations with lower N/P ratios. This effect 
has already been reported multiple times in the literature.[40] 
It may be explained by the fact that the stably transfected 
Figure 6. In vitro cytotoxicity analysis of naked DNA, WSLP, and WSLP/pEGFP-N3 at various N/P ratios on A) A549 and B) HeLa cells using MTT assay. 
Viability of the naked DNA, WSLP, and WSLP/pEGFP-N3 treated cells was normalized to the untreated controls.
Figure 7. Flow cytometric analysis of in vitro transfection efficiency. A) A549 and B) HeLa cells were transfected with WSLP/pEGFP-N3 complexes of 
various N/P ratios.
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cells may efficiently proliferate during the incubation after 
the transfection procedure. Indeed, the transfection efficiency 
reached 36.5% in the case of A549 cells and 64.3% in the case 
of HeLa cells. These values render this type of WSLP promising 
for its applicability in in vivo transfection experiments after 
the required optimization is achieved to reduce the cytotoxic 
side-effect.
The transfection efficiency using the pX458 plasmid was 
checked with WSLP, and also including the starting HMW PEI, 
as well as the commercial standard transfection reagent Lipo-
fectamine 3000 (Thermo Fisher Scientific) for comparison. The 
results included in Figure S6, Supporting Information, dem-
onstrated the high transfection efficiency of highly cytotoxic 
PEI, in agreement with the literature data.[20] The transfection 
efficiency of the WSLP at N/P 10/1 ratio was similar to Lipo-
fectamine. It is worth mentioning that the success of the trans-
fection experiments with the large pX458 plasmid (9289 base 
pairs; Figure S6, Supporting Information), was similar to that 
of pEGFP-N3 plasmid (4729 base-pairs; Figure  7), most prob-
ably due to the efficient condensation of the DNA in both cases.
As another proof of the successful gene delivery using WSLP/
DNA complexes, the direct visualization of gene expression of 
EGFP in A549 cells was confirmed using an inverted fluores-
cent microscope. Figure 8 clearly indicates that GFP expression 
is more intense in cells transfected with the WSLP/pDNA than 
with PEI/pDNA complexes at 10/1 N/P ratio. The fluorescence 
is more diffuse when PEI was applied instead of WSLP, which 
can be easily explained by the phase contrast images, showing 
that PEI is much more toxic than WSLP.
GFP expression was also observed using fluorescence 
microscopy after the transfected A549 cellular nuclei were 
stained with Hoechst 33432 fluorescent dye. Hoechst 33432 is 
a cell permeable fluorescent nuclear stain that specifically binds 
to DNA. In fluorescent microscopic experiments such nuclear 
stains are used to detect intactness of the nucleus, to assess 
the localization or colocalization of fluorescently labeled cel-
lular proteins, and to count total number of cells. The results 
revealed that more GFP was expressed using WSLP as trans-
fection agent than with PEI (Figure S7, Supporting Informa-
tion) and the high GFP fluorescence intensity was colocalized 
with the Hoechst fluorescence. In other words, the WSLP/DNA 
complexes showed higher intracellular distribution than PEI/
DNA.
3. Conclusion
In this work an EGFP (pEGFP-N3) and a CRISPR/Cas9 (pX458) 
carrier plasmid DNA both expressing the EGFP fluorescent 
protein for detectability of transfection were efficiently con-
densed by a water soluble lipopolymer. The WSLP consisted 
of positively charged hydrophilic PEI functionalized with 
lipophilic cholesterol. The cholesterylation was efficient, in 
average ≈10% of the PEI nitrogens were reacted. This kind of 
modification of a cytotoxic high molecular weight PEI seems 
to be promising, since it retains the positive charges for strong 
interaction with DNA, while decreasing the toxicity of the prep-
aration. The interaction between the lipopolymer and DNA 
was monitored by agarose gel electrophoresis, which clearly 
showed the lack of the free DNA at 5/1 and higher N/P ratios 
of the WSLP and DNA. The size of these nanoparticles was 
close to 100  nm. Electron microscopy showed that the DNA 
is condensed with the cationic WSLP, being important for the 
protection of the carried DNA against DNA degrading and 
damaging agents. Although previously it was found that the 
high molecular weight PEI is toxic to the cells,[17] we have found 
that our WSLP and the WSLP/DNA adducts did not show sig-
nificant toxicity at concentrations of ≈150  ng per well. How-
ever, the toxicity was dose and cell-line dependent. We could 
efficiently transfect A549 and HeLa cells under the applied 
conditions, which proved to be less efficient for Lipofectamine 
3000 standard transfection reagent similarly to the data found 
in the literature for small molecular weight PEI-based WSLP 
or similar gene carrier systems.[40,54] Nevertheless, the results 
indicate that the optimization of high molecular weight cationic 
polymers, such as the PEI, for gene delivery leads through the 
chemical modification of the polymer, and the minimization of 
the positive charge excess, needed to efficiently cross the mem-
brane. Similar direction of developing the new gene carriers 
are presented by studies using the minimum amount of high 
molecular weight PEI supplemented with low molecular weight 
PEI for increased transfection efficiency,[55] or regulating the 
charge of the polymer by optimizing the pH during the trans-
fection.[56] In addition, the combination of various agents such 
as amphiphilic copolymers or proteins, to obtain carriers with 
Figure 8. Fluorescence microscopic images of A549 cells transfected by 
WSLP/pEGFP-N3 complexes at 10/1 N/P ratio after 48 h incubation time. 
PEI was used for comparison. The scale bar represents 500 µm and it is 
same for all images in this figure.
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multifarious properties will lead to fine-tuning of the polymeric 
gene delivery systems.[57,58]
4. Experimental Section
Materials: PEI (30% m/v in water) was purchased from Tokyo 
Chemicals, trimethylamine ((C2H5)3N, 99%), methylene chloride 
(CH2Cl2, anhydrous, ≥99.8%), cholesteryl chloroformate (C28H45ClO2, 
95%), diethyl ether ((CH3CH2)2O, anhydrous, ≥99.7%) were purchased 
from Sigma, and acetone (CH3COCH3, ≥99%) was manufactured by 
Molar. The stock solutions were freshly prepared using MQ (Millipore, 
Milli-Q Integral3) ultrapure water (18.2 MΩ cm at 25  °C) in every 
case. The pSpCas9(BB)-2A-GFP (pX458) and the pEGFP-N3 plasmids 
were purchased from Addgene. The Qiagen Plasmid Mini Kit was 
purchased from Qiagen. The MTT reagent (3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium bromide), penicillin, and streptomycin were 
obtained from SERVA. Dulbecco's modified eagle medium (DMEM) fetal 
bovine serum and L-glutamine were purchased from Lonza.
Synthesis and Purification of the Water-Soluble Lipopolymer: The 
synthesis and the purification of WSLP were carried out based on the 
description in the literature[40] as shown schematically in Figure  1. 
3 g of PEI (10  mL PEI solution) was mixed with 10  mL ice-cold 
methylene chloride and 100 µL trimethylamine. Then 1 g of cholesteryl 
chloroformate was added to 5  mL chilled methylene chloride and this 
solution was slowly mixed with the PEI solution. The mixture was 
stirred at 0  °C using 800  rpm for 12 h resulting in a pale yellow solid 
product. The synthesized WSLP was purified by the following steps. 
First, the product was completely dried by rotary evaporation (IKA, RV 3 
evaporator), then the powder was dissolved into 50 mL of 0.1 m HCl, and 
an extraction was repeated three times using 50 mL methylene chloride. 
For the removal of the large aggregates, vacuum filtration was applied 
by standard P3 glass and paper filters with 16–40 and 3–5 µm pore size, 
respectively. The filtered liquid was concentrated by rotary evaporation 
(50 °C, 2 h) then the WSLP was precipitated by acetone and the filtration 
was repeated as described above. Finally, the solid WSLP was obtained 
by freeze drying (Christ Alpha, 1 2 LD dryer) for 1 day.
Determination of the Critical Micellar Concentration of the Water-Soluble 
Lipopolymer: The CMC of the WSLP was determined by following the 
fluorescence of the Eosin red indicator in the presence of an increasing 
amount of WSLP. Since the synthesized WSLP polymer had both a 
positively charged hydrophilic (imine moieties) and a hydrophobic 
(cholesterol) side chain, it was able to show surfactant-like behavior 
such as micelle formation. For the measurements, 5 mL of 20 µm Eosin 
red was mixed with 5  mL WSLP solution of varying concentrations 
between 0 and 1  mg mL−1. The fluorescence spectra were recorded by 
a Horiba, Jobin Yvon Fluoromax-4 spectrofluorometer using 1 cm quartz 
cuvette. The excitation wavelength was 490 nm, the emission maximum 
was 540 nm using 3–3 nm slits. The measurement data were analyzed 
with the Origin 8.5 software.
Particle Charge Measurements: The charge of the initial PEI and the 
synthesized WSLP was determined at pH =  7.4 using a PCD-04 type of 
Mütek Particle Charge Detector. Namely, 10 mL of 0.01 m SDS solution in 
the PCD cell was titrated separately with 25.2 mL of 0.3 mg L−1 PEI and 
26  mL of 0.6085  mg L−1 WSLP in 300 and 1000 µL steps, respectively. 
The streaming potential was recorded 30 s after each step. The 
measurements were analyzed and the charge neutralization point was 
appointed based on the sigmoidal shape of the charge titration curve. 
The possible extent of the PEI protonation, the cholesteryl substitution, 
and the presumable molecular weight of the synthesized WSLP were 
also calculated.
Amplification and Purification of the Plasmid DNA: Competent 
Escherichia coli DH5α cells were transformed by pX458 and pEGFP-N3 
plasmids and cultured in lysogeny broth media containing 0.1 mg mL−1 
ampicillin. The plasmids were then purified by Plasmid Mini Kit (Qiagen) 
and subsequent precipitation with polyethylene-glycol (PEG6000). 
The concentration of the DNA was determined by a NanoDrop Lite 
spectrophotometer (Thermo Fisher Scientific). Purity of the DNA 
samples was assessed prior to loading into the lipopolymer.
DNA Condensation by WSLP: WSLP and pDNA were mixed at various 
compositions in sterilized water and incubated for 15–20  min at room 
temperature to allow complex formation between the lipopolymer and 
the plasmid DNA. The samples were subjected to electrophoresis in 
1% m/v agarose gel in 1× tris-acetic acid-EDTA buffer at 100 V until the 
1× orange blue loading dye ran through 80% of the gel. The GeneRuler 
1 kb Plus DNA Ladder (Thermo Fisher Scientific) served as a DNA size 
marker. Ethidium bromide was used for DNA visualization. The plasmid 
DNA was analyzed by an UviDoc (UviTec Ltd.) gel documentation 
system.
Particle Size and Zeta Potential Measurements: The hydrodynamic 
diameter and the ζ-potential of the WSLP itself and the WSLP/pDNA 
complexes, as well as, the molecular weight of the initial lipopolymer 
were determined by dynamic and static light scattering (DLS and SLS, 
respectively) using a Malvern Zetasizer Nano ZS ZEN 4003 apparatus 
equipped with an He–Ne laser (λ = 633 nm) at 25 ± 0.1 °C. The refractive 
index gradient was calculated by a Mettler Toledo Excellence RM50 
refractometer. The morphology of the initial WSLP and the WSLP/
pDNA complexes was also examined by electron microscopy techniques. 
The SEM pictures were recorded by a Hitachi S-4700 Field Emission 
Scanning Electron Microscope using 20  kV accelerating voltage. For 
the TEM images, a Jeol JEM-1400plus equipment (Japan) with 120  keV 
accelerating voltage was applied and the samples were dropped on the 
surface of formvar-coated grid. The pictures were analyzed by ImageJ 
software.
The average molecular weight was determined by DLS measurements 
based on the Debye plot (KC/R as a function of the C concentration) 
using the Zimm equation (Equation [2]). The slope of the fitting provided 
the second virial coefficient (2A2) and the intercept yielded the reciprocal 
of the molecular weight (1/Mw).
= +
1 2
w
2
KC
R M P
A C  (2)
where K is a constant dependent on the sample dn/dc, C is the sample 
concentration in g  mL–1, R is the Rayleigh ratio (the ratio of scattered 
light intensity to incident light intensity), Mw is the average molecular 
weight, and A2 is the second virial coefficient. P is an angular dependent 
term (by default, assumed to be 1 for small molecules <15 nm radius).
Cell Culture: A549 human lung cancer cells and HeLa cervical 
adenocarcinoma cells were obtained from the American Type Culture 
Collection (ATCC, USA). Cells were maintained in DMEM (Lonza) 
supplemented with 10% fetal bovine serum (FBS), L-glutamine (2 mm), 
penicillin (100 IU mL−1), and streptomycin (50 µg mL−1) in a humidified 
atmosphere containing 5% CO2 at 37 °C.
Cytotoxicity Assay: The cytotoxicity of WSLP/pDNA complexes 
prepared according to the mass and N/P ratios was determined by MTT 
assay. A549 and HeLa cells were seeded at 5000 cells per well density in 
96-well plates and incubated for 24 h at 37 °C to reach 70% confluence. 
Then the medium was removed and the WSLP, WSLP/pEGFP-N3 
complexes were added to the cells in serum-free DMEM. Following 
the incubation at 37  °C for 24 and 48 h, the medium was removed 
and the cells were washed with phosphate buffered saline (PBS). Cell 
viability was assessed by adding the MTT reagent prepared in serum-
free DMEM to a final concentration of 0.5  mg mL−1. After incubation 
(1 h at 37  °C), the media was removed and 100 µL dimethyl sulfoxide 
(Serva Electrophoresis GmbH) was added to dissolve the formazan 
crystals. The absorbance was measured at 570 nm using Synergy HTX 
plate reader (BioTek-Hungary). Data were analyzed by GraphPad Prism 
7 software (GraphPad Software; San Diego, CA, USA), where untreated 
cells served as the control.
In Vitro Transfection: A549 and HeLa cells were seeded in 6-well tissue 
culture plates at a density of 2 × 105 cells per well in 10% FBS-containing 
DMEM and were left to grow. After the cells reached 70% confluency, 
the medium was replaced with serum-free DMEM and the cells were 
transfected with WSLP/pEGFP-N3 complexes at DNA concentration of 
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2.5 µg per well. After 24 h incubation at 37 °C, the medium was replaced 
by a DMEM medium supplemented with 10% FBS, L-glutamine, 
penicillin, and streptomycin in concentrations described above. The cells 
were incubated for an additional 48 h, then were trypsinized, washed, 
and resuspended in PBS. The transfection efficiency was detected by 
flow cytometry using FACSCalibur platform via quantification of EGFP 
fluorescence. The analysis of the fluorescence-activated cell sorting data 
was performed with FlowJo and Graphpad softwares.
Fluorescence Microscopy: To validate the results of the flow cytometry 
experiments, the transfection efficiency by fluorescence microscopy was 
assessed as well. For this, A549 cells were seeded on glass coverslips 
(VWR), placed into the wells of a 24-well plate and were left to grow. 
When the cells reached about 70% confluence the culture medium 
was replaced to serum-free DMEM and the cells were transfected with 
WSLP/pEGFP-N3 and with PEI/pEGFP-N3 complexes at 10/1 N/P ratio 
with DNA concentration of 0.75 µg per well. After 24 h the cells were 
washed with PBS and were left to grow for 48 h in FBS-containing 
culture medium. Cells were visualized by OLYMPUS BX51 fluorescence 
microscope and the photos were taken by Olympus DP70 camera 
(Olympus, Tokyo, Japan) with or without staining with 3.25 µm Hoechst 
33432 (Sigma-Aldrich) dye for 30 min.
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